| Peter Martin Schissler, MD | |
|
7500 Greenway Center Dr, Ste 430, Greenbelt, MD 20770-3502 | |
| (301) 345-5857 | |
| (301) 474-5621 |
| Full Name | Peter Martin Schissler |
|---|---|
| Gender | Male |
| Speciality | Geriatric Medicine |
| Experience | 47 Years |
| Location | 7500 Greenway Center Dr, Greenbelt, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831135243 | NPI | - | NPPES |
| PTAN 0265590001 | Other | SC | OTHER PROVIDER |
| 791841100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | D22780 (Maryland) | Primary |
| Entity Name | Peter M. Schissler Md P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336258383 PECOS PAC ID: 0446377568 Enrollment ID: O20110218000569 |
News Archive
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain.
Visual impairment that is not explained by refractive error is increasing, as is the prevalence of diabetes – particularly diabetes lasting 10 years or longer, show US study results.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies.
Researchers at the University of Michigan Life Sciences Institute and School of Public Health have discovered a new class of anti-biofilm compounds derived from marine microorganisms that show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.
This week, the U.S. Centers for Disease Control (CDC) Director, Dr. Tom Frieden, visited the Nigerian National TB and Leprosy Training Center (NTBLTC) to tour a multimillion dollar laboratory complex established by the Institute of Human Virology (IHV) of the University of Maryland School of Medicine in Baltimore, Maryland, and the Institute of Human Virology-Nigeria. This U.S.-Nigeria partnership was established in 2004 through funding from the CDC and the President's Emergency Plan For AIDS Relief (PEPFAR).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Martin Schissler, MD 7500 Greenway Center Dr, Ste 430, Greenbelt, MD 20770-3502 Ph: (301) 345-5857 | Peter Martin Schissler, MD 7500 Greenway Center Dr, Ste 430, Greenbelt, MD 20770-3502 Ph: (301) 345-5857 |
News Archive
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain.
Visual impairment that is not explained by refractive error is increasing, as is the prevalence of diabetes – particularly diabetes lasting 10 years or longer, show US study results.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies.
Researchers at the University of Michigan Life Sciences Institute and School of Public Health have discovered a new class of anti-biofilm compounds derived from marine microorganisms that show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.
This week, the U.S. Centers for Disease Control (CDC) Director, Dr. Tom Frieden, visited the Nigerian National TB and Leprosy Training Center (NTBLTC) to tour a multimillion dollar laboratory complex established by the Institute of Human Virology (IHV) of the University of Maryland School of Medicine in Baltimore, Maryland, and the Institute of Human Virology-Nigeria. This U.S.-Nigeria partnership was established in 2004 through funding from the CDC and the President's Emergency Plan For AIDS Relief (PEPFAR).
› Verified 7 days ago
Michael A Schwartz, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 7500 Hanover Pkwy, Suite 204, Greenbelt, MD 20770 Phone: 301-345-7878 | |
Gaurav Lakhanpal, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7300 Hanover Dr, Suite 104, Greenbelt, MD 20770 Phone: 301-486-4690 Fax: 301-486-4692 | |
Dr. Irfan Ahsan Khan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr, Suite 730, Greenbelt, MD 20770 Phone: 301-474-0400 Fax: 301-474-2686 | |
Mr. Ibrahim Jalloh, FNP Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 7500 Hanover Pkwy, Greenbelt, MD 20770 Phone: 301-441-8696 | |
Acquanetta Frazier, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8723 Greenbelt Rd Ste 201, Greenbelt, MD 20770 Phone: 301-552-9797 | |
Mushtaq Shah, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7227 Hanover Pkwy Ste A, Greenbelt, MD 20770 Phone: 301-220-0606 Fax: 301-513-9049 | |
Dr. Pimolvarn Limpuangthip, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 7721 Belle Point Dr, Greenbelt, MD 20770 Phone: 301-345-1272 Fax: 301-474-2671 |